Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Exploring the Role of Interleukin 11 in Cancer Progression, Patient Survival, and Therapeutic Insights Publisher Pubmed



Hassani M1 ; Mahdevar M2, 3 ; Peymani M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
  2. 2. Genius Gene, Genetics and Biotechnology Company, Isfahan, Iran
  3. 3. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Molecular Biology Reports Published:2024


Abstract

Background: The Interleukin (IL)-11 gene, which is one of the members of the cytokine family, has an oncogenic role in some cancers. The main goal of this study is to analyze IL-11 expression level in 14 prevalent cancers and highlights its role in patients’ survival, drug resistance, and sensitivities. Also, an association of this gene with metastasis and inflammation pathways has been investigated. Methods and results: Using the cancer genome atlas (TCGA) data, the level of IL-11 expression and its role in prognosis and survival rate were evaluated in 13 common cancers. Then, confirming the obtained in-silico outcomes, the relative expression level of this gene in colorectal cancer (CRC) samples and their adjusted tissues were assayed by the RT-qPCR method. Furthermore, to examine the association between IL-11 expression and drug resistance and sensitivity, PharmacoGX data was applied. The co-expression network was used to recognize the pathways in which IL-11 was involved. The results from the TCGA dataset indicated that the expression level of IL-11 increased significantly in 13 prevalence cancers compared to the control groups. Interestingly, this enhanced expression level is associated with a high rate of mortality in patients with bladder, stomach, colorectal, and endometrial cancers. Also, the co-expression network analysis showed a strong correlation between IL-11 and the genes of metastasis pathway and the genes related to the inflammation process. Finally, regarding drug sensitivity, IL-11 expression level can be introduced as a remarkable biomarker for cancer detection due to area under curve (AUC). Conclusion: Altered expression of the IL-11 gene is observed in 13 common cancers and is associated with prognosis and mortality rate in patients. Moreover, this gene can be considered a prognostic biomarker in different types of cancer, such as CRC. © The Author(s), under exclusive licence to Springer Nature B.V. 2024.
Related Docs
View other Related Docs
1. Tbx15 and Sdhb Expression Changes in Colorectal Cancer Serve As Potential Prognostic Biomarkers, Experimental and Molecular Pathology (2024)
2. Identification of Genes With High Heterogeneity of Expression As a Predictor of Different Prognosis and Therapeutic Responses in Colorectal Cancer: A Challenge and a Strategy, Cancer Cell International (2022)
3. Comparison of Interleukin 18 Gene Expression and Its Serum Level Between Iranian Colorectal Cancer (Crc) Patients and Healthy People, Biologia (2019)
4. An Overview of the Role of Interleukin-8 in Colorectal Cancer, Cytokine (2020)
5. Analysing Glycolysis-Related Genes Reveals the Prognostic and Diagnostic Relevance of Ier3 and Agrn in Colorectal Cancer, Genes and Genomics (2025)
6. Expression and Prognostic Significance of Stem Cell Marker Cd133 in Survival Rate of Patients With Colon Cancer, Oncology and Therapy (2022)
7. Single Nucleotide Polymorphism Rs10889677 in Mirnas Let-7E and Let-7F Binding Site of Il23r Gene Is a Strong Colorectal Cancer Determinant: Report and Meta-Analysis, Cancer Genetics (2019)
8. Predictive Value of Tissue Inhibitor of Metalloproteinases-1 and Carcinoembryonic Antigen Plasma Levels in Response to Chemotherapy in Patients With Metastatic Colorectal Cancer, Journal of Research in Medical Sciences (2014)
Experts (# of related papers)
View all Related Experts
Rasoul Salehi (6)
Mohammad Hossein Sanei (4)
Other Related Docs
9. Analysis of Tslc1 Expression in Colorectal Cancer Specimens by Immunohistochemistry, Journal of Isfahan Medical School (2012)
10. Analysis of Polymorphism and Expression Profile of Asic1 and Il-6 Genes in Patients With Gastric Cancer, Asian Pacific Journal of Cancer Prevention (2018)
11. Steroid Receptor Rna Activator Gene Footprint in the Progression and Drug Resistance of Colorectal Cancer Through Oxidative Phosphorylation Pathway, Life Sciences (2021)
12. Identification of Genes Related to Ribosomal Proteins in Colorectal Cancer: Exploring Their Potential As Biomarkers, Prognostic Indicators, and Therapeutic Targets, Molecular Biology Reports (2024)
13. Identification and Validation of Nf-Kb Pathway-Related Lncrna Upregulated in Ibd Patients, Gene Reports (2023)
14. Leng8-As1: A Prognostic Biomarker in Colorectal Cancer-Differential Expression and Clinical Implications, Indian Journal of Clinical Biochemistry (2024)
15. Serum Inflammatory Markers As Prognostic Marker for Nasopharyngeal Carcinoma With Liver Metastasis: A Multi-Center Retrospective Study, European Archives of Oto-Rhino-Laryngology (2024)
16. Assessment of Immuno-Histochemical Expression of Mbd1 in Colorectal Adenocarcinoma and Its Correlations With Prognostic Factors, Middle East Journal of Digestive Diseases (2020)
17. The Effects of Isoproterenol and Propranolol on Cytokine Profile Secretion by Cultured Tumor-Infiltrating Lymphocytes Derived From Colorectal Cancer Patients, Cell Journal (2012)
18. Evaluation of Relative Frequency of Single Nucleotide Polymorphism G870a (Rs9344) in Cyclind1 Gene in Colorectal Cancer Patients and Healthy Subjects of Isfahan Province, Iran, Journal of Isfahan Medical School (2016)
19. Ret Protein Expression in Colorectal Cancer; an Immunohistochemical Assessment, Asian Pacific Journal of Cancer Prevention (2021)
20. Evaluation of Antitumor Effects of Aspirin and Lgk974 Drugs on Cellular Signaling Pathways, Cell Cycle and Apoptosis in Colorectal Cancer Cell Lines Compared to Oxaliplatin Drug, Fundamental and Clinical Pharmacology (2020)
21. A Mirna-Binding Site Single Nucleotide Polymorphism in the 3′-Utr Region of the Nod2 Gene Is Associated With Colorectal Cancer, Medical Oncology (2014)
22. Exploring Conserved Mrna-Mirna Interactions in Colon and Lung Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
23. Meta-Analysis of Gene Signatures and Key Pathways Indicates Suppression of Jnk Pathway As a Regulator of Chemo-Resistance in Aml, Scientific Reports (2021)
24. Synergistic Anti-Proliferative Effects of Lenalidomide and Dexamethasone on the Ht-29 Cell Line Through Apoptotic Genes, International Journal of Cancer Management (2021)
25. Efficacy and Safety of Proposed Bevacizumab Biosimilar Be1040v in Patients With Metastatic Colorectal Cancer: A Phase Iii, Randomized, Double-Blind, Noninferiority Clinical Trial, Clinical Therapeutics (2020)
26. Study of P33 Tumor Suppressor Protein Expression in Normal and Cancerous Colorectal Tissues, Journal of Isfahan Medical School (2010)
27. Dysregulated of the Fam138e and Clrn1-As1 Lncrnas Could Be Diagnosis Biomarkers in Colorectal Cancer, Human Gene (2024)
28. The Association Between Cyclin D1 (Ccnd1) Rs9344 Aa Genotype and Increased Risk of Colorectal Cancer in an Iranian Population, Middle East Journal of Cancer (2020)
29. Evaluation of Cd133 Expression Rate in Colon Cancers With Immunohistochemistry Method and Its Relationship With Colon Cancer Prognosis, Immunopathologia Persa (2024)
30. Comparative Analysis of Apc Tumor Suppressor Protein Expression in Cancerous and Normal Colorectal Specimens by Immunohistochemistry, Journal of Isfahan Medical School (2012)
31. Evaluation of Sepp1 and Selenoprotein S Gene Polymorphisms (Rs7579 and Rs34713741) in Relation to Colorectal Cancer Susceptibility in Subset of Iranian Population: A Case–Control Study, Advanced Biomedical Research (2019)
32. Network Analysis of Common Genes Related to Esophageal, Gastric, and Colon Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
33. Gene Expression Profile Analysis of Colon Cancer Grade Ii Into Grade Iii Transition by Using System Biology, Gastroenterology and Hepatology from Bed to Bench (2019)
34. Cxcl-10: A New Candidate for Melanoma Therapy?, Cellular Oncology (2020)
35. A Comparative Survey on the Expression of P16 As a Tumor Suppressor Protein in Cancerous and Non-Cancerous Colorectal Tissue Samples Using Immunohistochemistry Method, Journal of Isfahan Medical School (2012)
36. The Decrease in Nkg2d+ Natural Killer Cells in Peripheral Blood of Patients With Metastatic Colorectal Cancer, Bratislava Medical Journal (2015)
37. Association of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio With Tumoral Differentiation in Colorectal Cancer, Gene Reports (2022)
38. A Prediction of the Crnde Role by Modulating Nf-Κb Pathway in Inflammatory Bowel Disease (Ibd), Biochemistry and Biophysics Reports (2024)
39. Decline in Peripheral Blood Nkg2d+Cd3+Cd56+ Nkt Cells in Metastatic Colorectal Cancer Patients, Bratislava Medical Journal (2018)
40. Ptgs2 (Cox2) 2765G>C Gene Polymorphism and Risk of Sporadic Colorectal Cancer in Iranian Population, Molecular Biology Reports (2012)
41. Identification of Significant Genes and Pathways Associated With Tenascin-C in Cancer Progression by Bioinformatics Analysis, Advanced Biomedical Research (2022)
42. Metabolic Phenotypes and Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis of Cohort Studies, BMC Cancer (2022)
43. Tim3 and Pd-1 As a Therapeutic and Prognostic Targets in Colorectal Cancer: Relationship With Sidedness, Clinicopathological Parameters, and Survival, Frontiers in Oncology (2023)
44. Stat3 As a Newly Emerging Target in Colorectal Cancer Therapy: Tumorigenesis, Therapy Response, and Pharmacological/Nanoplatform Strategies, Environmental Research (2023)
45. A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis, Current Therapeutic Research - Clinical and Experimental (2024)
46. The Stromelysin-1 5A/5A Genotype Enhances Colorectal Cancer Cell Invasion in Iranian Population, Journal of Research in Medical Sciences (2012)
47. Exploring Slc30a6 As a Potential Prognostic, Immunomodulatory, and Therapeutic Biomarker in Various Cancers With a Focus on Pancreatic Cancer: A Pan-Cancer Analysis, Egyptian Journal of Medical Human Genetics (2024)
48. The Relationship Between Programmed Cell Death Receptor-1 Expression in Colon Tumoral Tissue and Clinical and Pathological Characteristics of Patients With Colon Cancer; [ارتباط بیان گیرنده ی مرگ برنامه ریزی شده 1 در بافت تومورال روده ی بزرگ با ویژگی های بالینی و آسیب شناسی بیماران مبتلا به سرطان روده ی بزرگ], Journal of Isfahan Medical School (2023)
49. Construction of a Cell Cycle-Specific Lncrna-Mirna-Mrna Network Reveals Novel Key Lncrnas in Colorectal Cancer, Biomarkers (2024)
50. Novel Biomarkers for Neoplastic Progression From Ulcerative Colitis to Colorectal Cancer: A Systems Biology Approach, Scientific Reports (2023)